{"id":1515,"date":"2021-11-12T04:27:52","date_gmt":"2021-11-12T04:27:52","guid":{"rendered":"https:\/\/launxp.com\/?p=1515"},"modified":"2024-10-24T05:33:13","modified_gmt":"2024-10-24T05:33:13","slug":"launxp-biomedical-obtained-patent-licensing-form-national-health-research-institutes-nhri","status":"publish","type":"post","link":"https:\/\/launxp.com\/cn\/news\/launxp-biomedical-obtained-patent-licensing-form-national-health-research-institutes-nhri\/","title":{"rendered":"\u56fd\u536b\u9662\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u6297\u764c\u65b0\u836f\u6280\u672f\u79fb\u8f6c\u6717\u9f50\u751f\u533b"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"1515\" class=\"elementor elementor-1515\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>From left, National Health Research Institutes&#8217; (NHRI) Institute of Biotechnology and Pharmaceutical Research (IBPR) Director Chang Jang-yang, Launxp Biomedical Co board member Ko Chun-pei and general manager Chen Chiu-heng, IBPR researcher Hsieh Hsing-pang and NHRI Chief Secretary Wu Hsiu-ying attend a news conference in Taipei yesterday.Photo: CNA Cancer drug to Start human trials next year [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":996,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[19],"class_list":["post-1515","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-biotech"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/posts\/1515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/comments?post=1515"}],"version-history":[{"count":14,"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/posts\/1515\/revisions"}],"predecessor-version":[{"id":1608,"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/posts\/1515\/revisions\/1608"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/media\/996"}],"wp:attachment":[{"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/media?parent=1515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/categories?post=1515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/launxp.com\/cn\/wp-json\/wp\/v2\/tags?post=1515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}